Clerkenwell Health

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Depression4 trials

Phase

• Phase 26 trials
• Phase 32 trials
• Phase 1/21 trial

Status

• Completed6 trials
• Active, not recruiting2 trials
• Terminated1 trial

Lead sponsor

• Beckley Psytech Limited2 trials
• Transcend Therapeutics2 trials
• Actinogen Medical1 trial
• atai Therapeutics, Inc.1 trial
• COMPASS Pathways1 trial
• and 2 more

Running trials

• Active, not recruiting

  A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

  NCT06809595· Phase 3· Definium Therapeutics US, Inc.· Source

• Active, not recruiting

  Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD

  NCT05711940· Phase 3· COMPASS Pathways· Source

Closed trials

• Completed

  A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)

  NCT06524830· Phase 2· atai Therapeutics, Inc.· Source

• Completed

  An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD

  NCT06215261· Phase 2· Transcend Therapeutics· Source

• Completed

  BPL-003 Efficacy and Safety in Treatment Resistant Depression

  NCT05870540· Phase 2· Beckley Psytech Limited· Source

• Completed

  An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder

  NCT05674929· Phase 2· Beckley Psytech Limited· Source

• Terminated

  Phase 2 Clinical Trial of GH001 in Postpartum Depression

  NCT05804708· Phase 2· GH Research Ireland Limited· Source

• Completed

  A Study to Assess the Use of Methylone in the Treatment of PTSD

  NCT05741710· Phase 1/2· Transcend Therapeutics· Source

• Completed

  Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)

  NCT05657691· Phase 2· Actinogen Medical· Source